H.C. Wainwright analyst Amit Dayal lowered the firm’s price target on Amyris to $5 from $22 and keeps a Buy rating on the shares. The firm now expects the company’s revenue to grow annually at 21.5% from 2024 to 2032, compared to a previous estimate of 29.4%. The most important near-term driver for the stock stems from demonstrated cuts in operating costs to allow the company to benefit from high gross margin revenues, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMRS:
- AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
- Amyris sees FY23 revenue growth 95%-100%, consensus $505.65M
- Amyris reports Q4 EPS (46c), consensus (27c)
- Amyris options imply 21.0% move in share price post-earnings
- Amyris options imply 16.3% move in share price post-earnings